Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000202600 | SCV000409976 | benign | Obesity | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Personalized Diabetes Medicine Program, |
RCV000445452 | SCV000537109 | benign | Monogenic diabetes | 2019-01-18 | criteria provided, single submitter | research | ACMG criteria: BP4 (REVEL 0.050 + 6 predictors; not using PP3/4 predictors), BA1 (overall MAF in gnomAD 1.6%; over 2% in multiple subpop), BS2 (51 homozygotes in gnomAD, 237 cases and 277 controls in type2diabetesgenetics.org)=benign |
Labcorp Genetics |
RCV002057039 | SCV002403135 | benign | not provided | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002057039 | SCV005312069 | benign | not provided | criteria provided, single submitter | not provided | ||
UCL Genetics Institute, |
RCV000202600 | SCV000257526 | protective | Obesity | 2014-12-23 | no assertion criteria provided | case-control | |
Clinical Molecular Genetics Laboratory, |
RCV000202600 | SCV000692298 | uncertain significance | Obesity | 2014-09-18 | no assertion criteria provided | clinical testing | |
OMIM | RCV000768671 | SCV000900038 | benign | MELANOCORTIN 4 RECEPTOR POLYMORPHISM | 1999-04-01 | no assertion criteria provided | literature only | |
OMIM | RCV000768672 | SCV000900039 | protective | OBESITY, RESISTANCE TO | 1999-04-01 | no assertion criteria provided | literature only | |
Clinical Genetics, |
RCV001699064 | SCV001924236 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001699064 | SCV001926975 | benign | not specified | no assertion criteria provided | clinical testing | ||
Imperial College London Diabetes Centre, |
RCV001778791 | SCV002014764 | pathogenic | BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 | 2020-05-01 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003977552 | SCV004797497 | benign | MC4R-related disorder | 2021-11-08 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |